ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 686

Development and Evaluation of the Combined Ankylosing Spondylitis Spine Score (CASSS) for the Assessment of Spinal Radiographic Outcome

Fiona Maas1, Anneke Spoorenberg1,2, Elisabeth Brouwer1, Hendrika Bootsma3, Reinhard Bos2, Freke Wink2 and Suzanne Arends1,2, 1Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands, 2Rheumatology, Medical Center Leeuwarden, Leeuwarden, Netherlands, 3Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, The Netherlands, Groningen, Netherlands

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Ankylosing spondylitis (AS), outcome measures and radiography

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 13, 2016

Title: Spondylarthropathies and Psoriatic Arthritis – Clinical Aspects and Treatment - Poster I: Axial and Peripheral Spondyloarthritis – Clinical Aspects, Imaging and Treatment

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Spinal radiographic progression is a highly variable process in ankylosing spondylitis (AS). Our aim was to develop a combined AS spine score (CASSS) in which the cervical facet joint score is combined with the mSASSS, and to investigate the additional value of the CASSS in the evaluation of spinal radiographic progression in AS patients.

Methods: Baseline and 4-year radiographs from 98 consecutive AS patients treated with TNF-α inhibitors in the GLAS cohort were scored by two readers; vertebral bodies according to mSASSS (0-72) and cervical facet joints (C2-C7) according to the method of de Vlam (0-15). The CASSS was calculated by summing up the total scores of both methods (range 0-87) and was compared to mSASSS (gold standard) using three aspects of the OMERACT filter: feasibility, discrimination, and truth.

Results: Feasibility: Scoring cervical facet joints took a few minutes, no additional radiographs were necessary. The CASSS could be calculated in 91 (93%) and mSASSS in 94 (96%) patients. Discrimination: Both scoring methods had very good inter-observer reliability (ICC’s status scores >0.99, progression scores 0.92). Measurement error was similar for CASSS and mSASSS, smallest detectable change was 1.9 and 1.8, resp. Sensitivity to change was moderate for both methods with a standardized response mean of 0.63 for CASSS and 0.59 for mSASSS. Truth: The use of CASSS resulted in 41 (46%) patients with higher baseline scores and 22 (25%) with higher progression scores compared to mSASSS. Baseline damage of facet joints was moderately correlated with damage of vertebral bodies (rho=0.49). Radiographic progression of facet joints was not correlated with progression of vertebral bodies (rho=0.16).

Conclusion: According to the OMERACT filter, the new CASSS performed similar to mSASSS in respect to feasibility and discrimination. The CASSS showed better truth value since it provides a broader range of structural changes and captures more AS patients with progression which is very important in the evaluation of radiographic outcome in this heterogeneous and slowly progressing disease.


Disclosure: F. Maas, None; A. Spoorenberg, Abbvie, Pfizer, UCB, 2,Abbvie, Pfizer, MSD, UCB, and Novartis, 5; E. Brouwer, Roche Pharmaceuticals, 5; H. Bootsma, None; R. Bos, None; F. Wink, Abbvie, 5; S. Arends, Pfizer, 2.

To cite this abstract in AMA style:

Maas F, Spoorenberg A, Brouwer E, Bootsma H, Bos R, Wink F, Arends S. Development and Evaluation of the Combined Ankylosing Spondylitis Spine Score (CASSS) for the Assessment of Spinal Radiographic Outcome [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/development-and-evaluation-of-the-combined-ankylosing-spondylitis-spine-score-casss-for-the-assessment-of-spinal-radiographic-outcome/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/development-and-evaluation-of-the-combined-ankylosing-spondylitis-spine-score-casss-for-the-assessment-of-spinal-radiographic-outcome/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology